Healthcare Global Enterprises Stock Screener | Share Price & Fundamental Analysis
HCG
Hospitals
Screen Healthcare Global Enterprises share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹659.50
▲
2.20 (0.33%)
Share Price BSE
₹659.10
▲
2.50 (0.38%)
Market Cap
₹9,204.98 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
10.15
EPS (TTM)
₹3.19
Dividend Yield
-
Debt to Equity
1.78
52W High
₹776.30
52W Low
₹471.70
Operating Margin
18.00%
Profit Margin
1.18%
Revenue (TTM)
₹594.00
EBITDA
₹114.00
Net Income
₹7.00
Total Assets
₹3,543.00
Total Equity
₹990.00
Healthcare Global Enterprises Share Price History - Stock Screener Chart
Screen HCG historical share price movements with interactive charts. Analyze price trends and patterns.
Healthcare Global Enterprises Company Profile - Fundamental Screener
Screen Healthcare Global Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HCG shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE075I01017
Healthcare Global Enterprises Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen HCG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,543 | 2,708 | 2,316 | 2,220 | 2,036 | 2,253 | 1,654 | 1,444 | 1,226 | 1,034 |
| Current Assets | 844 | 680 | 580 | 502 | 435 | 304 | 273 | 220 | 244 | 201 |
| Fixed Assets | 2,442 | 1,758 | 1,553 | 1,547 | 1,382 | 1,646 | 970 | 828 | 685 | 568 |
| Liabilities | ||||||||||
| Total Liabilities | 3,543 | 2,708 | 2,316 | 2,220 | 2,036 | 2,253 | 1,654 | 1,444 | 1,226 | 1,034 |
| Current Liabilities | 1,507 | 1,099 | 876 | 866 | 856 | 1,258 | 584 | 506 | 371 | 270 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 990 | 865 | 869 | 884 | 714 | 420 | 522 | 579 | 490 | 569 |
| Share Capital | 139 | 139 | 139 | 139 | 125 | 89 | 88 | 87 | 86 | 85 |
| Reserves & Surplus | 783 | 687 | 721 | 731 | 528 | 293 | 389 | 398 | 347 | 451 |
Screen HCG income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 594 | 619 | 648 | 502 | 534 | 564 | 563 | 446 | 463 | 489 | 475 | 367 | 410 | 421 | 428 |
| Expenses | 480 | 505 | 524 | 403 | 435 | 451 | 470 | 365 | 386 | 402 | 391 | 302 | 336 | 345 | 349 |
| EBITDA | 114 | 114 | 125 | 100 | 99 | 112 | 93 | 80 | 76 | 87 | 84 | 65 | 74 | 76 | 78 |
| Operating Profit % | 18.00% | 17.00% | 19.00% | 18.00% | 17.00% | 18.00% | 16.00% | 17.00% | 16.00% | 17.00% | 17.00% | 17.00% | 18.00% | 18.00% | 18.00% |
| Depreciation | 58 | 58 | 63 | 46 | 47 | 50 | 57 | 42 | 41 | 43 | 44 | 41 | 40 | 41 | 41 |
| Interest | 44 | 46 | 44 | 27 | 34 | 36 | 41 | 26 | 26 | 27 | 30 | 24 | 25 | 26 | 27 |
| Profit Before Tax | 14 | 12 | 20 | 28 | 19 | 28 | -3 | 13 | 11 | 18 | 11 | 1 | 10 | 10 | 11 |
| Tax | 7 | 6 | -1 | 5 | 5 | 7 | -11 | 8 | 7 | 7 | 8 | -1 | 8 | 5 | 7 |
| Net Profit | 7 | 6 | 21 | 24 | 14 | 21 | 8 | 6 | 4 | 11 | 3 | 2 | 3 | 5 | 4 |
| EPS | 0.53 | 0.34 | 1.16 | 1.53 | 0.87 | 1.29 | 0.50 | 0.60 | 0.55 | 0.97 | 0.41 | 0.43 | 0.44 | 0.53 | 0.54 |
Healthcare Global Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen HCG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 317 | 285 | 252 | 220 | 121 | 130 | 99 | 98 | 91 | 73 |
| Investing Activities | -488 | -226 | -133 | 125 | -171 | -101 | -238 | -283 | -210 | -204 |
| Financing Activities | -42 | -64 | -140 | -155 | 112 | -58 | 84 | 161 | 89 | 216 |
| Net Cash Flow | -213 | -5 | -22 | 190 | 62 | -30 | -56 | -24 | -29 | 85 |
Screen HCG shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.22% | 62.46% | 63.78% | 71.28% | 71.25% | 71.23% | 71.23% | 71.37% |
| FII Holding | 2.45% | 2.16% | 3.59% | 6.74% | 3.95% | 4.29% | 2.77% | 0.00% |
| DII Holding | 12.47% | 13.22% | 18.36% | 8.52% | 10.89% | 11.64% | 12.94% | 5.54% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.43% | 10.50% | 10.41% | 9.39% | 9.41% | 9.33% | 9.60% | 11.44% |
| Other Holding | 3.43% | 11.66% | 3.86% | 4.07% | 4.49% | 3.50% | 3.46% | 11.65% |
| Shareholder Count | 45,394 | 47,028 | 46,970 | 27,195 | 26,529 | 29,670 | 32,820 | 28,858 |
Healthcare Global Enterprises Dividend Screener - Share Yield Analysis
Screen HCG dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Healthcare Global Enterprises Index Membership - Market Screener Classification
Screen HCG by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Healthcare Global Enterprises Market Events Screener - Corporate Actions
Screen HCG market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -6.31% | ||
| Annual General Meeting | NA | 5.42% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.96% |
| 2025-08-01 | 2025-08-01 | Quarterly Result Announcement | NA | 9.75% |
| 2025-05-24 | 2025-05-24 | Quarterly Result Announcement | NA | 7.76% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.69% |
| 2024-11-09 | 2024-11-09 | Quarterly Result Announcement | NA | 10.51% |
Healthcare Global Enterprises Competitors Screener - Peer Comparison
Screen HCG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 102,252 | 58.57 | 21,994 | 14.76% | 1,505 | 46.86 |
| Max Healthcare Institute | 102,082 | 74.90 | 7,184 | 28.65% | 1,076 | 38.86 |
| Fortis Healthcare | 67,988 | 64.26 | 7,850 | 13.25% | 809 | 49.90 |
| Narayana Hrudayalaya | 39,532 | 45.71 | 5,575 | 12.29% | 790 | 57.19 |
| Global Health | 32,037 | 56.77 | 3,771 | 12.59% | 481 | 51.45 |
| Aster DM Healthcare | 31,434 | 87.54 | 4,287 | 15.12% | 337 | 40.34 |
| Krishna Institute of Medical Sciences | 24,653 | 68.29 | 3,067 | 21.98% | 415 | 33.50 |
| Dr. Agarwal's Health Care | 15,831 | 110.83 | 1,757 | 27.64% | 110 | 47.42 |
| Kovai Medical Center Hospital | 13,964 | 27.53 | 600 | 11.69% | 58 | 34.31 |
| Rainbow Childrens Medicare | 13,359 | 52.58 | 1,567 | 17.46% | 244 | 41.00 |
Healthcare Global Enterprises Company Announcements - News Screener
Screen HCG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-04 | Closure of Trading Window | View |
| 2025-12-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-12-28 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-12-04 | Audio Recording Of The Virtual Investor & Analyst Meet Held On December 04 2025. | View |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-12-01 | Appointment Of Internal Auditor Of The Company Under Section 138 Of The Companies Act 2013. | View |
| 2025-12-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-13 | Unaudited Financial Results (Standalone And Consolidated) For Quarter And Six Months Ended September 30 2025- Searchable And Legible Format. | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-11-12 | Issuance Of Guarantee In The Form Of A Standby Letter Of Credit (SBLC) To Secure Credit Facilities Proposed To Be Availed By Cancer Care Kenya Limited Step-Down Subsidiary Of The Company In Kenya For Its Business Expansion. | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-12 | Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Six Months Ended September 30 2025. | View |
| 2025-11-12 | Board Meeting Outcome for Approval Of Unaudited Financial Results Of The Company (Standalone And Consolidated) For The Quarter And Six Months Ended September 30 2025. | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |